Martin Hutchings, MD, PhD, Copenhagen University Hospital
Advertisement
Articles by Martin Hutchings, MD, PhD, Copenhagen University Hospital
Advertisement
Latest Updated Articles
Rapid Readouts: Phase 1/2 Study of Epcoritamab in R/R B-cell NHLJanuary 28th 2021
Advertisement
Advertisement
Trending on OncLive
1
Ofirnoflast Elicits Durable Transfusion Independence, Hematologic Improvement in Lower-Risk MDS
2
Revumenib Plus Chemo Yields High Response and MRD-Negativity Rates in Newly Diagnosed NPM1+ or KMT2A+ AML
3
ACTIVE Regimen Elicits High Response Rates in R/R NPM1-Mutated AML
4
Dr Gangat on Phase 2 Efficacy and Safety Data for DISC-3405 in Polycythemia Vera
5